PATH
Menu

This case study highlights PATH and our partners’ successful advocacy efforts to ensure the protection of vaccines containing thiomersal—a preservative used in multi-dose vaccines. In January 2013, government delegates finalized a global environmental treaty on mercury having agreed to exclude vaccines containing the preservative thiomersal from further regulation.

Corporate author(s): PATH

Publication date: July 2013

Available materials

English

Protecting Global Access to Lifesaving Vaccines

99 KB PDF

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Global

See also:

Vaccines and immunizationMiscellaneous

For advocates and policymakersChild health

For advocates and policymakersAdvocacy strategy

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA